CN1158569A - 用于治疗骨质疏松症的雌激素和甲状腺素 - Google Patents

用于治疗骨质疏松症的雌激素和甲状腺素 Download PDF

Info

Publication number
CN1158569A
CN1158569A CN95195016A CN95195016A CN1158569A CN 1158569 A CN1158569 A CN 1158569A CN 95195016 A CN95195016 A CN 95195016A CN 95195016 A CN95195016 A CN 95195016A CN 1158569 A CN1158569 A CN 1158569A
Authority
CN
China
Prior art keywords
bone
osteoporosis
parathyroid hormone
estrogen
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN95195016A
Other languages
English (en)
Chinese (zh)
Inventor
J·A·贝文
A·D·格迪斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CN1158569A publication Critical patent/CN1158569A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CN95195016A 1994-09-09 1995-09-06 用于治疗骨质疏松症的雌激素和甲状腺素 Pending CN1158569A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30392694A 1994-09-09 1994-09-09
US08/303,926 1994-09-09

Publications (1)

Publication Number Publication Date
CN1158569A true CN1158569A (zh) 1997-09-03

Family

ID=23174293

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95195016A Pending CN1158569A (zh) 1994-09-09 1995-09-06 用于治疗骨质疏松症的雌激素和甲状腺素

Country Status (8)

Country Link
EP (1) EP0804202A4 (fr)
JP (1) JP2001503728A (fr)
KR (1) KR970705397A (fr)
CN (1) CN1158569A (fr)
AU (1) AU3674895A (fr)
CA (1) CA2199250A1 (fr)
IL (1) IL115225A0 (fr)
WO (1) WO1996007416A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545635A (en) * 1995-05-23 1996-08-13 Eli Lilly And Company Inhibiting bone loss with equilenin
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
CN101355959B (zh) 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
EP2509996A1 (fr) 2009-12-07 2012-10-17 Michigan Technological University Hormone parathyroïde de l'ours noir et ses procédés d'utilisation
WO2015057836A2 (fr) * 2013-10-15 2015-04-23 The Trustees Of Columbia University In The City Of New York Hormone parathyroïdienne anabolique osseuse et analogues de protéine apparentée à l'hormone parathyroïdienne

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
TW303299B (fr) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
EP0804202A1 (fr) 1997-11-05
JP2001503728A (ja) 2001-03-21
WO1996007416A1 (fr) 1996-03-14
KR970705397A (ko) 1997-10-09
EP0804202A4 (fr) 1999-01-13
IL115225A0 (en) 1995-12-31
CA2199250A1 (fr) 1996-03-14
AU3674895A (en) 1996-03-27

Similar Documents

Publication Publication Date Title
Hay Bone disease in cholestatic liver disease
RU2112515C1 (ru) Способ лечения остеопороза
JP3727332B2 (ja) 骨粗鬆症の治療方法
CN1269721A (zh) 用非天然存在的fp选择性激动剂增加骨容量的方法
Cunnane et al. STEROID–INDUCED OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Kim et al. Treatment of medication-related osteonecrosis of the jaw around the dental implant with a once-weekly teriparatide: a case report and literature review
Combe et al. Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin
CN1158569A (zh) 用于治疗骨质疏松症的雌激素和甲状腺素
Gonnelli et al. Treatment of post‐menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study
Pontiroli et al. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study
EP1221966B1 (fr) Utilisation d'une hormone parathyroide pour reduire les risques de cancer
CN1157565A (zh) 用骨活性膦酸盐和甲状旁腺激素治疗骨质疏松症的方法
CN1157566A (zh) 用于骨质疏松症的膦酸盐类和甲状旁腺激素
JPH0873376A (ja) 骨粗鬆症治療薬
Cascella et al. Effects of neridronate treatment in elderly women with osteoporosis
CN100479823C (zh) 双膦酸盐在制造药物套盒中的用途以及用于增加骨质的套盒
CN1301160A (zh) 用于治疗肌与骨骼脆弱的(选择性)雌激素受体调节剂(serm)和生长激素促分泌剂(ghs)的治疗用联合形式
JP2005520810A (ja) 骨再生を促進するカルモジュリンの使用
JPH10506638A (ja) アレンドロネート又はその塩の投与による歯喪失の予防
HK1087039B (en) Use of biphosphonate in preparing medical kit and a kit used for increasing bone mass
Dequeker Joint and musculoskeletal
JP2002538122A (ja) 天然に存在しないｆｐ選択的アゴニストおよび骨吸収抑制化合物を用いる骨体積の増加方法
CN101052410A (zh) 促进骨形成和保持的方法
HK1030545B (en) Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture
HK1030545A1 (en) Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication